CliniCal trials done at 14 hospitals

> First indigenously designed and manufactured artificial aortic valve are for patients with a high risk or are unwilling to undergo open heart valve replacement surgery

> The Transcatheter Aortic Heart Valve Replacement is a minimally invasive procedure

> The approval is after successful results from a clinical trial done in India, involving 14 hospitals > The first patient to receive Myval has completed 1.5 years and is living a symptom-free productive life